Royal Bank Of Canada Pacific Biosciences Of California, Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 27,916 shares of PACB stock, worth $49,132. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,916
Previous 44,302
36.99%
Holding current value
$49,132
Previous $60,000
21.67%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PACB
# of Institutions
255Shares Held
228MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$58.8 Million0.54% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$41.6 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$41.2 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$35.7 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$31.1 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $396M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...